Review: Molecular mechanism of microglia stimulated glioblastoma invasion

Matrix Biology

Volumn 32, Issue 7-8, 2013, Pages 372-380

  Coniglio, Salvatore J ^a   Segall, Jeffrey E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

CSF 1R; Glioma; Invasion; Macrophages; Microglia; MMPs; TGF

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; FIBRONECTIN; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 18; MATRIX METALLOPROTEINASE 14; OSTEOPONTIN; PROTEINASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN RECEPTOR; VITRONECTIN;

ANTIGEN PRESENTING CELL; CANCER GROWTH; EPITHELIAL MESENCHYMAL TRANSITION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; MACROPHAGE; MICROGLIA; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR MICROENVIRONMENT; UPREGULATION;

CSF-1R; GLIOMA; INVASION; MACROPHAGES; MICROGLIA; MMPS; TGFΒ;

CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; GLIOBLASTOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICROGLIA; NEOPLASM INVASIVENESS; PARACRINE COMMUNICATION; PEPTIDE HYDROLASES; SIGNAL TRANSDUCTION;

EID: 84889095438     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.07.008     Document Type: Review

References (170)

1. Alves T.R., Lima F.R., Kahn S.A., Lobo D., Dubois L.G., Soletti R., et al. Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. Life Sci. 2011, 89:532-539.
2. Anido J., Saez-Borderias A., Gonzalez-Junca A., Rodon L., Folch G., Carmona M.A., et al. TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell 2011, 18:655-668.
3. Arima K., Watanabe N., Hanabuchi S., Chang M., Sun S.C., Liu Y.J. Distinct signal codes generate dendritic cell functional plasticity. Sci. Signal. 2010, 3:ra4.
4. Atai N.A., Bansal M., Lo C., Bosman J., Tigchelaar W., Bosch K.S., et al. Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology 2011, 132:39-48.
5. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
6. Badie B., Schartner J. Role of microglia in glioma biology. Microsc. Res. Tech. 2001, 54:106-113.
7. Badie B., Schartner J., Klaver J., Vorpahl J. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 1999, 44:1077-1082. (discussion 1082-3).
8. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
9. Bao S., Wu Q., Li Z., Sathornsumetee S., Wang H., McLendon R.E., et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008, 68:6043-6048.
10. Bassi R., Giussani P., Anelli V., Colleoni T., Pedrazzi M., Patrone M., et al. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J. Neurooncol. 2008, 87:23-33.
11. Belien A.T., Paganetti P.A., Schwab M.E. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 1999, 144:373-384.
12. Bender A.M., Collier L.S., Rodriguez F.J., Tieu C., Larson J.D., Halder C., et al. Sleeping beauty-mediated somatic mutagenesis implicates CSF1 in the formation of high-grade astrocytomas. Cancer Res. 2010, 70:3557-3565.
13. Bettinger I., Thanos S., Paulus W. Microglia promote glioma migration. Acta Neuropathol. 2002, 103:351-355.
14. Bierie B., Moses H.L. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 2010, 21:49-59.
15. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
16. Biswas S.K., Chittezhath M., Shalova I.N., Lim J.Y. Macrophage polarization and plasticity in health and disease. Immunol. Res. 2012, 53:11-24.
17. Boimel P.J., Smirnova T., Zhou Z.N., Wyckoff J., Park H., Coniglio S.J., et al. Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res. 2012, 14:R23.
18. Bravo-Cordero J.J., Oser M., Chen X., Eddy R., Hodgson L., Condeelis J. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr. Biol. 2011, 21:635-644.
19. Bruna A., Darken R.S., Rojo F., Ocana A., Penuelas S., Arias A., et al. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 2007, 11:147-160.
20. Buckner J.C., Brown P.D., O'Neill B.P., Meyer F.B., Wetmore C.J., Uhm J.H. Central nervous system tumors. Mayo Clin. Proc. 2007, 82:1271-1286.
21. Charles N.A., Holland E.C., Gilbertson R., Glass R., Kettenmann H. The brain tumor microenvironment. GLIA 2012, 60:502-514.
22. Chen W.T., Wang J.Y. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann. N. Y. Acad. Sci. 1999, 878:361-371.
23. Cheng P., Corzo C.A., Luetteke N., Yu B., Nagaraj S., Bui M.M., et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J. Exp. Med. 2008, 205:2235-2249.
24. Chernov A.V., Sounni N.E., Remacle A.G., Strongin A.Y. Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells. J. Biol. Chem. 2009, 284:12727-12734.
25. Chitu V., Stanley E.R. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 2006, 18:39-48.
26. Condeelis J., Singer R.H., Segall J.E. The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu. Rev. Cell Dev. Biol. 2005, 21:695-718.
27. Coniglio S.J., Eugenin E., Dobrenis K., Stanley E.R., West B.L., Symons M.H., et al. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol. Med. 2012, 18:519-527.
28. Corzo C.A., Cotter M.J., Cheng P., Cheng F., Kusmartsev S., Sotomayor E., et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 2009, 182:5693-5701.
29. Deryugina E.I., Bourdon M.A., Luo G.X., Reisfeld R.A., Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. J. Cell Sci. 1997, 110(Pt 19):2473-2482.
30. Deryugina E.I., Luo G.X., Reisfeld R.A., Bourdon M.A., Strongin A. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer. Res. 1997, 17:3201-3210.
31. Deryugina E.I., Bourdon M.A., Reisfeld R.A., Strongin A. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 1998, 58:3743-3750.
32. Deryugina E.I., Ratnikov B., Monosov E., Postnova T.I., DiScipio R., Smith J.W., et al. MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 2001, 263:209-223.
33. Douglass T.G., Driggers L., Zhang J.G., Hoa N., Delgado C., Williams C.C., et al. Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies. Int. Immunopharmacol. 2008, 8:1354-1376.
34. Dziurzynski K., Wei J., Qiao W., Hatiboglu M.A., Kong L.Y., Wu A., et al. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin. Cancer Res. 2011, 17:4642-4649.
35. Dziurzynski K., Chang S.M., Heimberger A.B., Kalejta R.F., McGregor Dallas S.R., Smit M., et al. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012, 14:246-255.
36. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
37. El Kasmi K.C., Holst J., Coffre M., Mielke L., de Pauw A., Lhocine N., et al. General nature of the STAT3-activated anti-inflammatory response. J. Immunol. 2006, 177:7880-7888.
38. El Kasmi K.C., Smith A.M., Williams L., Neale G., Panopoulos A.D., Watowich S.S., et al. Cutting edge: a transcriptional repressor and corepressor induced by the STAT3-regulated anti-inflammatory signaling pathway. J. Immunol. 2007, 179:7215-7219.
39. El-Obeid A., Bongcam-Rudloff E., Sorby M., Ostman A., Nister M., Westermark B. Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro. Cancer Res. 1997, 57:5598-5604.
40. Evans R.D., Itoh Y. Analyses of MT1-MMP activity in cells. Methods Mol. Med. 2007, 135:239-249.
41. Farber K., Synowitz M., Zahn G., Vossmeyer D., Stragies R., van Rooijen N., et al. An alpha5beta1 integrin inhibitor attenuates glioma growth. Mol. Cell. Neurosci. 2008, 39:579-585.
42. Flugel A., Labeur M.S., Grasbon-Frodl E.M., Kreutzberg G.W., Graeber M.B. Microglia only weakly present glioma antigen to cytotoxic T cells. Int. J. Dev. Neurosci. 1999, 17:547-556.
43. Fonseca A.C., Romao L., Amaral R.F., Assad Kahn S., Lobo D., Martins S., et al. Microglial stress inducible protein 1 promotes proliferation and migration in human glioblastoma cells. Neuroscience 2012, 200:130-141.
44. Forsyth P.A., Wong H., Laing T.D., Rewcastle N.B., Morris D.G., Muzik H., et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br. J. Cancer 1999, 79:1828-1835.
45. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007, 21:2683-2710.
46. Gabrusiewicz K., Ellert-Miklaszewska A., Lipko M., Sielska M., Frankowska M., Kaminska B. Characteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomas. PLoS One 2011, 6:e23902.
47. Galarneau H., Villeneuve J., Gowing G., Julien J.P., Vallieres L. Increased glioma growth in mice depleted of macrophages. Cancer Res. 2007, 67:8874-8881.
48. Gately C.L., Muul L.M., Greenwood M.A., Papazoglou S., Dick S.J., Kornblith P.L., et al. In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack. J. Immunol. 1984, 133:3387-3395.
49. Ghosh A., Chaudhuri S. Microglial action in glioma: a boon turns bane. Immunol. Lett. 2010, 131:3-9.
50. Giese A., Bjerkvig R., Berens M.E., Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J. Clin. Oncol. 2003, 21:1624-1636.
51. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2011, 330:841-845.
52. Gladson C.L., Prayson R.A., Liu W.M. The pathobiology of glioma tumors. Annu. Rev. Pathol. 2010, 5:33-50.
53. Gondi C.S., Lakka S.S., Dinh D.H., Olivero W.C., Gujrati M., Rao J.S. Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol. 2004, 1:165-176.
54. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 2005, 65:5278-5283.
55. Gritsenko P.G., Ilina O., Friedl P. Interstitial guidance of cancer invasion. J. Pathol. 2012, 226:185-199.
56. Guzhova I., Kislyakova K., Moskaliova O., Fridlanskaya I., Tytell M., Cheetham M., et al. In vitro studies show that Hsp70 can be released by glia and that exogenous Hsp70 can enhance neuronal stress tolerance. Brain Res. 2001, 914:66-73.
57. Halatsch M.E., Schmidt U., Behnke-Mursch J., Unterberg A., Wirtz C.R. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours. Cancer Treat. Rev. 2006, 32:74-89.
58. Hao C., Parney I.F., Roa W.H., Turner J., Petruk K.C., Ramsay D.A. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol. 2002, 103:171-178.
59. Held-Feindt J., Hattermann K., Muerkoster S.S., Wedderkopp H., Knerlich-Lukoschus F., Ungefroren H., et al. CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Exp. Cell Res. 2010, 316:1553-1566.
60. Hernandez L., Magalhaes M.A., Coniglio S.J., Condeelis J.S., Segall J.E. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis. Breast Cancer Res. 2012, 13:R128.
61. Hoa N.T., Zhang J.G., Delgado C.L., Myers M.P., Callahan L.L., Vandeusen G., et al. Human monocytes kill M-CSF-expressing glioma cells by BK channel activation. Lab. Invest. 2007, 87:115-129.
62. Hoa N., Myers M.P., Douglass T.G., Zhang J.G., Delgado C., Driggers L., et al. Molecular mechanisms of paraptosis induction: implications for a non-genetically modified tumor vaccine. PLoS One 2009, 4:e4631.
63. Hoelzinger D.B., Demuth T., Berens M.E. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J. Natl. Cancer Inst. 2007, 99:1583-1593.
64. Holbro T., Civenni G., Hynes N.E. The ErbB receptors and their role in cancer progression. Exp. Cell Res. 2003, 284:99-110.
65. Huettner C., Czub S., Kerkau S., Roggendorf W., Tonn J.C. Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer. Res. 1997, 17:3217-3224.
66. Hussain S.F., Yang D., Suki D., Grimm E., Heimberger A.B. Innate immune functions of microglia isolated from human glioma patients. J. Transl. Med. 2006, 4:15.
67. Hynes N.E., MacDonald G. ErbB receptors and signaling pathways in cancer. Curr. Opin. Cell Biol. 2009, 21:177-184.
68. Ikushima H., Miyazono K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 2010, 10:415-424.
69. Itoh Y. MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life 2006, 58:589-596.
70. Itoh Y., Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol. 2006, 206:1-8.
71. Itoh Y., Ito N., Nagase H., Seiki M. The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface. J. Biol. Chem. 2008, 283:13053-13062.
72. Jacobs V.L., Landry R.P., Liu Y., Romero-Sandoval E.A., De Leo J.A. Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol. 2012, 14:119-131.
73. Jacobs V.L., Liu Y., De Leo J.A. Propentofylline targets TROY, a novel microglial signaling pathway. PLoS One 2012, 7:e37955.
74. Jan H.J., Lee C.C., Shih Y.L., Hueng D.Y., Ma H.I., Lai J.H., et al. Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro Oncol. 2010, 12:58-70.
75. Johnson G.B., Brunn G.J., Kodaira Y., Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 2002, 168:5233-5239.
76. Johnson G.B., Brunn G.J., Platt J.L. Activation of mammalian Toll-like receptors by endogenous agonists. Crit. Rev. Immunol. 2003, 23:15-44.
77. Johnson G.B., Brunn G.J., Platt J.L. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J. Immunol. 2004, 172:20-24.
78. Kees T., Lohr J., Noack J., Mora R., Gdynia G., Todt G., et al. Microglia isolated from patients with glioma gain antitumor activities on poly (I:C) stimulation. Neuro Oncol. 2012, 14:64-78.
79. Kerber M., Reiss Y., Wickersheim A., Jugold M., Kiessling F., Heil M., et al. Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res. 2008, 68:7342-7351.
80. Kesanakurti D., Chetty C., Dinh D.H., Gujrati M., Rao J.S. Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with alpha5beta1 integrin in glioma. Oncogene 2013, 32:327-340.
81. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
82. Kielian T., van Rooijen N., Hickey W.F. MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J. Neurooncol. 2002, 56:1-12.
83. Kim S., Takahashi H., Lin W.W., Descargues P., Grivennikov S., Kim Y., et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009, 457:102-106.
84. Komohara Y., Ohnishi K., Kuratsu J., Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J. Pathol. 2008, 216:15-24.
85. Kwiatkowska A., Symons M. Signaling determinants of glioma cell invasion. Adv. Exp. Med. Biol. 2013, 986:121-141.
86. Lakka S.S., Jasti S.L., Gondi C., Boyd D., Chandrasekar N., Dinh D.H., et al. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 2002, 21:5601-5608.
87. Lamour V., Le Mercier M., Lefranc F., Hagedorn M., Javerzat S., Bikfalvi A., et al. Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model. Int. J. Cancer 2010, 126:1797-1805.
88. Lampert K., Machein U., Machein M.R., Conca W., Peter H.H., Volk B. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am. J. Pathol. 1998, 153:429-437.
89. Landry R.P., Jacobs V.L., Romero-Sandoval E.A., DeLeo J.A. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp. Neurol. 2012, 234:340-350.
90. Lathia J.D., Li M., Hall P.E., Gallagher J., Hale J.S., Wu Q., et al. Laminin alpha 2 enables glioblastoma stem cell growth. Ann. Neurol. 2012, 72:766-778.
91. Leung S.Y., Wong M.P., Chung L.P., Chan A.S., Yuen S.T. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. 1997, 93:518-527.
92. Li W., Graeber M.B. The molecular profile of microglia under the influence of glioma. Neuro Oncol. 2012, 14:958-978.
93. Libermann T.A., Nusbaum H.R., Razon N., Kris R., Lax I., Soreq H., et al. Amplification and overexpression of the EGF receptor gene in primary human glioblastomas. J. Cell Sci. Suppl. 1985, 3:161-172.
94. Libermann T.A., Nusbaum H.R., Razon N., Kris R., Lax I., Soreq H., et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985, 313:144-147.
95. Lin E.Y., Pollard J.W. Macrophages: modulators of breast cancer progression. Novartis Found. Symp. 2004, 256:158-168. (discussion 168-72, 259-69).
96. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 2001, 193:727-740.
97. Lin E.Y., Jones J.G., Li P., Zhu L., Whitney K.D., Muller W.J., et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 2003, 163:2113-2126.
98. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006, 66:11238-11246.
99. Lin H.C., Song T.Y., Hu M.L. S-Adenosylhomocysteine promotes the invasion of C6 glioma cells via increased secretion of matrix metalloproteinase-2 in murine microglial BV2 cells. Toxicol. Sci. 2009, 112:322-330.
100. Mantovani A., Sica A., Allavena P., Garlanda C., Locati M. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation. Hum. Immunol. 2009, 70:325-330.
101. Mantovani A., Biswas S.K., Galdiero M.R., Sica A., Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 2013, 229:176-185.
102. Marigo I., Dolcetti L., Serafini P., Zanovello P., Bronte V. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 2008, 222:162-179.
103. Markovic D.S., Glass R., Synowitz M., Rooijen N., Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J. Neuropathol. Exp. Neurol. 2005, 64:754-762.
104. Markovic D.S., Vinnakota K., Chirasani S., Synowitz M., Raguet H., Stock K., et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12530-12535.
105. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
106. Massague J., Seoane J., Wotton D. Smad transcription factors. Genes Dev. 2005, 19:2783-2810.
107. Matusan-Ilijas K., Behrem S., Jonjic N., Zarkovic K., Lucin K. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma. Pathol. Oncol. Res. 2008, 14:293-298.
108. McAllister S.S., Gifford A.M., Greiner A.L., Kelleher S.P., Saelzler M.P., Ince T.A., et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 2008, 133:994-1005.
109. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
110. Nakada M., Nakada S., Demuth T., Tran N.L., Hoelzinger D.B., Berens M.E. Molecular targets of glioma invasion. Cell Mol. Life Sci. 2007, 64:458-478.
111. Nakada M., Kita D., Teng L., Pyko I.V., Watanabe T., Hayashi Y., et al. Receptor tyrosine kinases: principles and functions in glioma invasion. Adv. Exp. Med. Biol. 2013, 986:143-170.
112. Nakano A., Tani E., Miyazaki K., Yamamoto Y., Furuyama J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 1995, 83:298-307.
113. Okada M., Saio M., Kito Y., Ohe N., Yano H., Yoshimura S., et al. Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int. J. Oncol. 2009, 34:1621-1627.
114. Oser M., Condeelis J. The cofilin activity cycle in lamellipodia and invadopodia. J. Cell. Biochem. 2009, 108:1252-1262.
115. Oser M., Dovas A., Cox D., Condeelis J. Nck1 and Grb2 localization patterns can distinguish invadopodia from podosomes. Eur. J. Cell Biol. 2011, 90:181-188.
116. Oser M., Mader C.C., Gil-Henn H., Magalhaes M., Bravo-Cordero J.J., Koleske A.J., et al. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J. Cell Sci. 2011, 123:3662-3673.
117. Page-McCaw A., Ewald A.J., Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 2007, 8:221-233.
118. Pixley F.J., Stanley E.R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 2004, 14:628-638.
119. Platten M., Wick W., Wild-Bode C., Aulwurm S., Dichgans J., Weller M. Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. Biochem. Biophys. Res. Commun. 2000, 268:607-611.
120. Platten M., Wick W., Weller M. Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc. Res. Tech. 2001, 52:401-410.
121. Poincloux R., Lizarraga F., Chavrier P. Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia. J. Cell Sci. 2009, 122:3015-3024.
122. Pollard J.W. Trophic macrophages in development and disease. Nat. Rev. Immunol. 2009, 9:259-270.
123. Prados M.D., Lamborn K.R., Chang S., Burton E., Butowski N., Malec M., et al. Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro Oncol. 2006, 8:67-78.
124. Prinz M., Mildner A. Microglia in the CNS: immigrants from another world. GLIA 2011, 59:177-187.
125. Raithatha S.A., Muzik H., Rewcastle N.B., Johnston R.N., Edwards D.R., Forsyth P.A. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro Oncol. 2000, 2:145-150.
126. Ramnarain D.B., Park S., Lee D.Y., Hatanpaa K.J., Scoggin S.O., Otu H., et al. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells. Cancer Res. 2006, 66:867-874.
127. Rangaswami H., Kundu G.C. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways. Oncol. Rep. 2007, 18:909-915.
128. Rangaswami H., Bulbule A., Kundu G.C. Nuclear factor inducing kinase: a key regulator in osteopontin-induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation. Glycoconj. J. 2006, 23:221-232.
129. Rangaswami H., Bulbule A., Kundu G.C. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 2006, 16:79-87.
130. Rao J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 2003, 3:489-501.
131. Reardon D.A., Herndon J.E., Peters K.B., Desjardins A., Coan A., Lou E., et al. Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients. Br. J. Cancer 2012, 107:1481-1487.
132. Rich J.N., Bao S. Chemotherapy and cancer stem cells. Cell Stem Cell 2007, 1:353-355.
133. Rich J.N., Reardon D.A., Peery T., Dowell J.M., Quinn J.A., Penne K.L., et al. Phase II trial of gefitinib in recurrent glioblastoma. J. Clin. Oncol. 2004, 22:133-142.
134. Rodrigues J.C., Gonzalez G.C., Zhang L., Ibrahim G., Kelly J.J., Gustafson M.P., et al. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol. 2010, 12:351-365.
135. Serafini P., Borrello I., Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 2006, 16:53-65.
136. Sica A., Larghi P., Mancino A., Rubino L., Porta C., Totaro M.G., et al. Macrophage polarization in tumour progression. Semin. Cancer Biol. 2008, 18:349-355.
137. Sidani M., Wyckoff J., Xue C., Segall J.E., Condeelis J. Probing the microenvironment of mammary tumors using multiphoton microscopy. J. Mammary Gland Biol. Neoplasia 2006, 11:151-163.
138. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., et al. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
139. Smirnova T., Zhou Z.N., Flinn R.J., Wyckoff J., Boimel P.J., Pozzuto M., et al. Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis. Oncogene 2011, 31:706-715.
140. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997, 159:4772-4780.
141. Teodorczyk M., Martin-Villalba A. Sensing invasion: cell surface receptors driving spreading of glioblastoma. J. Cell. Physiol. 2010, 222:1-10.
142. Tran Thang N.N., Derouazi M., Philippin G., Arcidiaco S., Di Berardino-Besson W., Masson F., et al. Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. Cancer Res. 2011, 70:4829-4839.
143. Varol C., Yona S., Jung S. Origins and tissue-context-dependent fates of blood monocytes. Immunol. Cell Biol. 2009, 87:30-38.
144. Veeravalli K.K., Rao J.S. MMP-9 and uPAR regulated glioma cell migration. Cell Adh. Migr. 2012, 6:509-512.
145. Veeravalli K.K., Chetty C., Ponnala S., Gondi C.S., Lakka S.S., Fassett D., et al. MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice. PLoS One 2010, 5:e11583.
146. Villeneuve J., Tremblay P., Vallieres L. Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation. Cancer Res. 2005, 65:3928-3936.
147. Wagner S., Stegen C., Bouterfa H., Huettner C., Kerkau S., Roggendorf W., et al. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10. J. Neurooncol. 1998, 40:113-122.
148. Wagner S., Czub S., Greif M., Vince G.H., Suss N., Kerkau S., et al. Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int. J. Cancer 1999, 82:12-16.
149. Wai P.Y., Kuo P.C. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev. 2008, 27:103-118.
150. Wang W., Wyckoff J.B., Goswami S., Wang Y., Sidani M., Segall J.E., et al. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res. 2007, 67:3505-3511.
151. Wang S.C., Hong J.H., Hsueh C., Chiang C.S. Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab. Invest. 2012, 92:151-162.
152. Watters J.J., Schartner J.M., Badie B. Microglia function in brain tumors. J. Neurosci. Res. 2005, 81:447-455.
153. Wei J., Barr J., Kong L.Y., Wang Y., Wu A., Sharma A.K., et al. Glioma-associated cancer-initiating cells induce immunosuppression. Clin. Cancer Res. 2010, 16:461-473.
154. Wei J., Wu A., Kong L.Y., Wang Y., Fuller G., Fokt I., et al. Hypoxia potentiates glioma-mediated immunosuppression. PLoS One 2011, 6:e16195.
155. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507.
156. Wesolowska A., Kwiatkowska A., Slomnicki L., Dembinski M., Master A., Sliwa M., et al. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion-an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. Oncogene 2008, 27:918-930.
157. Wick W., Platten M., Weller M. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J. Neurooncol. 2001, 53:177-185.
158. Wu A., Wei J., Kong L.Y., Wang Y., Priebe W., Qiao W., et al. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol. 2010, 12:1113-1125.
159. Wyckoff J.B., Wang Y., Lin E.Y., Li J.F., Goswami S., Stanley E.R., et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007, 67:2649-2656.
160. Xue C., Wyckoff J., Liang F., Sidani M., Violini S., Tsai K.L., et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res. 2006, 66:192-197.
161. Yan W., Qian C., Zhao P., Zhang J., Shi L., Qian J., et al. Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells. Neuro Oncol. 2010, 12:765-775.
162. Ye X.Z., Xu S.L., Xin Y.H., Yu S.C., Ping Y.F., Chen L., et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J. Immunol. 2012, 189:444-453.
163. Yeh W.L., Lu D.Y., Liou H.C., Fu W.M. A forward loop between glioma and microglia: glioma-derived extracellular matrix-activated microglia secrete IL-18 to enhance the migration of glioma cells. J. Cell. Physiol. 2011, 227:558-568.
164. Yeung Y.T., Bryce N.S., Adams S., Braidy N., Konayagi M., McDonald K.L., et al. p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells. J. Neurooncol. 2012, 109:35-44.
165. Yi L., Xiao H., Xu M., Ye X., Hu J., Li F., et al. Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma. J. Neuroimmunol. 2011, 232:75-82.
166. Yona S., Jung S. Monocytes: subsets, origins, fates and functions. Curr. Opin. Hematol. 2010, 17:53-59.
167. Youn J.I., Gabrilovich D.I. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 2011, 40:2969-2975.
168. Zagzag D., Miller D.C., Chiriboga L., Yee H., Newcomb E.W. Green fluorescent protein immunohistochemistry as a novel experimental tool for the detection of glioma cell invasion in vivo. Brain Pathol. 2003, 13:34-37.
169. Zeineddine N.S., Avina M.D., Williams C.C., Wepsic H.T., Jadus M.R. Macrophages that kill glioma cells expressing the membrane form of macrophage colony stimulating factor are resistant to prostaglandin E2 and interleukin-10. Immunol. Lett. 1999, 70:63-68.
170. Zhai H., Heppner F.L., Tsirka S.E. Microglia/macrophages promote glioma progression. GLIA 2011, 59:472-485.